RecruitingNCT07426211

Impact of Shift Work on Glucose and Lipid Metabolism of Hospital Workers

Sponsor

Olga Ramich (formerly Pivovarova)

Enrollment

48 participants

Start Date

Jun 1, 2026

Study Type

OBSERVATIONAL

Conditions

Shift-work Disorder Chronodisruption Glucose and Lipid Metabolism

Summary

The aim of the study is to evaluate circadian glucose, activity and dietary rhythms, as well as metabolic and cardiovascular risk associated with night shift work, sleep quality and well-being in a cohort of hospital staff, comparing employees with night shifts to employees without night shifts.

Eligibility

Min Age: 18 YearsMax Age: 67 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with chronodisruption, glucose and lipid metabolism, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 67 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(2)

Charité - Universitätsmedizin Berlin, CharitéCentrum für Anästhesiologie und Intensivmedizin (CC 07) + CIP - Charité Intensivpflege

Berlin, Germany

Charité-Universitaetsmedizin Berlin, Department of Anesthesiology and Intensive Care Medicine (CCM/CVK)

Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07426211

Related Trials

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

NCT0656836749 locations

Night Shift Work and Biomarkers of Obesity Risk in Hospital and Industry Workers

NCT062885681 location